Drugs / LMX4
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00847093 | Sep 2008 → Jul 2009 | — | Ferndale Laboratories, Inc. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00187135 Comparator | Mar 2002 → Aug 2008 | bone marrow disorder | St. Jude Children's Research Hospital | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LMX-4 | “The tube will contain either a local anesthetic cream (LMX-4)® or a cream with no active medicine (a placebo).” NCT00847093 ↗ |
| Route | Topical | “applying the skin-numbing-cream EMLA or L.M.X4™ on the area where the procedure is performed” NCT00187135 ↗ |